Precision Neuroscience Raises $102M to Challenge Elon Musk’s Neuralink in Brain Implant Race

We are a physician-led company, and our objective is to make a meaningful, positive difference in people’s lives.
In 2021, a team led by neurosurgeon and engineer Ben Rapoport embarked on an ambitious journey to bridge the gap between artificial intelligence and human thought. Precision Neuroscience was born with a clear focus: improving the lives of people with severe neurological conditions through brain-computer interfaces (BCI). Less than three years later, the company has now raised a $102 million Series C round, marking a critical milestone in its mission and positioning itself firmly alongside, if not against, Elon Musk’s Neuralink. The latest round, led by General Equity Holdings, comes with notable participation from Steadview Capital, B Capital, and the Duquesne Family Office, headed by prominent investor Stanley Druckenmiller. With this funding, Precision Neuroscience’s total capital
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of Anshika Mathews
Anshika Mathews
Anshika is the Senior Content Strategist for AIM Research. She holds a keen interest in technology and related policy-making and its impact on society. She can be reached at anshika.mathews@aimresearch.co
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.